CORRESPONDENCE NPM/ALK rearrangements in indolent cutaneous lesions

TO THE EDITOR
The (2;5)(p23;q35) translocation, which results in the fusion of the NPM (nucleophosmin) gene on chromosome 5q35 with the novel ALK (anaplastic lymphoma kinase) gene on chromosome 2p23, is associated with Ki-1 (CD30)-positive anaplastic large cell lymphomas (ALCL). 1, 2 In the present study we searched for NPM/ALK rearrangements in a group of patients with different lymphoid malignancies, employing nested RT-PCR. This series included eight ALCL (six nodal, one cutaneous and one case arising from a peripheral non-Hodgkin's lymphoma (NHL) with a T cell phenotype), 15 NHL, seven HD, three LyP including one case of a patient with Mycosis fungoides and three cases with atypical cutaneous lymphoid infiltrates. We also analysed ALK and p53 status by immunohistochemical techniques (IHC). SSCP of p53 was performed on DNA samples obtained from cases with NPM/ALK rearrangements.
Total RNA was extracted from frozen tissue samples using a guanidium isothiocyanate-based method (Ultraspec RNA isolation system; Biotecx Laboratories, Houston, TX, USA). A nested RT-PCR was set up to amplify the NPM/ALK transcript using the primers 5ЈNMP-S1 TCC-CTTGGGGGCTTTGAAATAACACC and 3Ј-ALK1 CGAGGTGCGGAGC-TTGCTCAGC as described previously 1 and 5ЈNPM-S2 GTGGTC-TTTAAGGTTGAAGTGTGG and 3Ј ALK-A2 AGGGCTCTGCAG-CTCCATCTG for the nested PCR.
To test sample quality NPM/NPM cDNA was amplified using the primers 5ЈNPM-S1 and 3ЈNPM GCTACGACCTCCAGGGGCAGA. 10 l of each PCR step were electrophoresed on a 3% Nusieve agarose (FMC, Rockland, MD, USA) Gel for UV analysis yielding a 177 bp fragment after the first step and a 117-bp fragment after the second step. Identification of the transcript was confirmed by direct sequencing. SSCP analysis of p53 was performed as previously described.
3
Mixing experiments using SU-DHL-1 and Daudi cell line indicated that the sensitivity of the nested PCR analyses were 1 in 10 5 cells (Figure 1 ).
Nested PCR gave a fragment of 117 bp in eight cases (see Table 1 ). There were no positive samples in the NHL or HD groups. SSCP analysis showed an abnormal electrophoretic mobility in three cases (patients 1, 2 and 5) all in exon 6. Sequence analysis of these polymorphic bands showed a point mutation at codon 213 (CGA→CGG). TaqI restriction analysis confirmed these findings. This corresponds to a common polymorphism. 4 Using a sensitive method we were able to detect NPM/ALK transcripts in 5/8 ALCL. Positive cases included three nodal ALCL, one cutaneous ALCL and one case that was secondary. Application of RT-PCR to cutaneous lymphoproliferation is problematic. Beylot-Barry et al 5 found NPM/ALK rearrangements in LyP and primary cutaneous ALCL. However, when these cases were studied by IHC using ALK and DNA-PCR, the majority of the cases proved to be negative.
6 These results were in accordance with previous papers reporting NPM/ALK negativity in cutaneous ALCL and LyP. 7 This discordance could be clinically important. In fact, we detected the NPM/ALK transcript in a girl with a cutaneous lymphoid infiltrate that spontaneously regressed without therapy. In another case, diagnosed as cutaneous ALCL, IHC was negative for ALK and the patient showed a benign evolution (patient 5). Recently, NPM/ALK fusion cDNA has been found in peripheral blood of healthy individuals.
8 p53 mutation and/or overexpression exert a negative influence on survival in patients with B cell non-Hodgkin's lymphoma.
3 However, direct correlation between p53 expression and the presence of p53 mutation does not exist in ALCL.
The major practical conclusions that could be drawn from our work are: (1) RT-PCR is a sensitive technique to identify NPM/ALK rearrangements in nodal ALCL; and (2) its application to cutaneous lymphoid proliferation is limited by the fact that it could be positive even in cases with an indolent course.
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Leukaemias in Zambia
TO THE EDITOR There are distinct differences between subSaharan Africa and the industrialized countries as to the age and gender distributions of the leukaemias. 1 In subSaharan Africa, incidence of acute lymphoblastic leukaemia (ALL) is low (Ͻ1/100 000/year); the deficit is specifically of common ALL (c-ALL) in children under 5 years of age.
2 T-ALL is the more common form with a peak frequency at 5 to 14 years of age.
1 In the past 12 years, however, c-ALL has been observed with increasing frequency in Black children in South Africa and Zimbabwe.
3,4 Acute myeloid leukaemia (AML) is diagnosed with equal frequency as ALL in children in tropical Africa, and is especially common in boys aged 5 to 14 years, who present often with chloromas, usually arising in the orbit.
1 Chronic granulocytic leukaemia (CGL) is seen generally at younger ages and up to 20% of CGL in some series occurred in children.
1 In tropical Africa, chronic lymphocytic leukaemia (CLL) shows a male to female (M:F) ratio of 1:1 overall, but below the age of 45 years the M:F is 1:2, while above that age it is 2:1 as in the western world. The 'African' CLL in younger mostly female adults is associated with multiparity, poverty and rural habitation. Patients present typically with gross splenomegaly and only moderate lymphadenopathy.
5
From the few reports of leukaemias in Zambians it may be concluded that age and gender distributions of leukaemias in Zambia resemble those of other subSaharan tropical African countries. 6 The present communication describes the age-specific frequencies and gender distributions of the leukaemias diagnosed over a 3-year period (1995) (1996) (1997) in the capital city, Lusaka. Attention was focused on whether there was an increase in the frequency of cALL in childhood, and on the immunophenotypic classification of the chronic lymphoproliferative disorders presenting as CLL. Cells from patients presenting from May 1996 onwards with acute leukaemias and chronic lymphoproliferative disorders were subjected to immunophenotyping utilizing the FACScan. The research protocol was approved by the Research Ethics Committee of the University of Zambia.
ALL was seen in 11 children (eight males, three females) aged less than 15 years, and 16 adults (nine males, seven females): only four were aged less than 5 years. Overall the M:F ratio was 1:0.59 ( Figure  1) . FAB classification was L1 in four, L2 in 21 and L3 in two.
Immunophenotyping was performed on nine ALL. Seven carried T cell markers. Three were pre T-ALL (CD7+ve, CD3+ve, CD2−ve, CD5−ve, CD4−ve, CD8−ve). One was early T-ALL (CD7+ve, CD3+ve, CD2+ve, CD5+ve, CD4−ve CD8−ve). Three were cortical T-ALL (CD7+ve, CD3+ve, CD2+ve, CD5+ve, CD4+ve CD8± in two, and CD4+ve CD8+ve in one). The patients with T-ALL were five males (aged 4 to 20 years) and two females (aged 32 and 37 years): two of the seven were children. Two ALL were classified as c-ALL (CD19+ve, CD22+ve, CD10+ve): the patients were a male aged 10 and a female aged 20 years. The distribution of ALL by age, gender and FAB classification was typical for tropical Africa.
1,2 T-ALL was the commonest phenotype (seven out of nine tested), and arose from cells of varying degrees of differentiation from pre-T to cortical T cells. Neither of the two patients with cALL was aged below 5 years. There is not yet in Zambia any apparent increase in the frequency of c-ALL in childhood, as has been described in the Black populations of South Africa and Zimbabwe. 3, 4 Whatever are the changes in the environment which have increased the risk of developing cALL in childhood in southern Africa, such as improved hygiene delaying exposure to certain infections, population mixing resulting from urbanization and no prolonged breastfeeding, these have not yet had any impact on the frequency of the disease in Zambia. c-ALL remains a rarity in Zambian adults also, as it does in South Africa.
3 AML was diagnosed in eight children (four males, four females), and nine adults (four males, five females). The overall M:F was 1:1.13 ( Figure 1 ). None had chloroma at the time of presentation, but this has been described in a previous Zambian study. 6 The most common FAB classification was M1 (five), followed by M2 (four) and M3 (four, of which three were hypogranular variants): other types seen were M4, M5 (one each) and M6 (two). AML was confirmed immunophenotypically in all five tested (CD13+ve, CD33+ve).
Of the 19 patients with CGL, five (21%) were children, the youngest patient being a girl aged 6 years. The overall M:F was 1:0.91 ( Figure  1 ). One leukaemia was in the accelerated phase and three were in blastic crisis when first diagnosed. Immunophenotypic markers demonstrated that one blastic transformation was myeloid.
It is probable that the high relative frequency in childhood and young adults reflects not a high age specific incidence, but only the distribution by age of the population.
1 The high relative frequency of CGL in childhood (5/24 leukaemias) could also be a result of its more indolent course compared to acute leukaemias, and hence a greater chance of presentation at hospital.
Three men and nine women had CLL (M:F = 1:3). Three women were aged less than 45 years, of whom two were diagnosed on light microscopy as having prolymphocytic leukaemia (PLL) (Figure 1) . None had cells suggestive of hairy cell leukaemia (HCL) or splenic lymphoma with villous lymphocytes (SLVL). Typical B-CLL was con-
